Selank: The Anti-Anxiety Peptide That Researchers Are Watching Closely

In a world where anxiety research is more relevant than ever, Selank has quietly become one of the more interesting peptides being studied. It comes from the same Russian research tradition as Semax, and it has drawn the attention of biohacking researchers specifically because of what it appears not to do as much as what it does.

What Is Selank?

Selank is a synthetic analog of tuftsin, a naturally occurring tetrapeptide that plays a role in immune system regulation. By modifying the tuftsin molecule and adding additional amino acids to stabilize it, Russian researchers created a compound that appears to produce anxiolytic (anti-anxiety) effects through a mechanism unlike anything currently common in pharmacology.

Like Semax, Selank was developed at the Institute of Molecular Genetics in Russia and has gone through clinical evaluation there. It is approved in Russia for anxiety-related conditions, giving it a longer research history than many peptides entering Western research pipelines.

What Does the Research Show?

The most striking aspect of Selank research is what studies show about its anxiolytic effect profile:

• Anxiolytic effects without sedation: In animal models and early human studies, Selank has shown anti-anxiety effects without the sedation, muscle relaxation, or cognitive impairment typically associated with benzodiazepines. Researchers find this a particularly important distinction.
• No dependence signals in research models: Studies in animal models have not shown signs of physical dependence or withdrawal — a major difference from classical anxiolytics in research comparisons.
• Serotonin and dopamine system effects: Research suggests Selank may modulate serotonergic and dopaminergic neurotransmission, connecting to its observed effects on mood and anxiety markers in research settings.
• Enkephalin system interactions: Studies show Selank may slow the breakdown of enkephalins — naturally occurring opioid peptides in the brain — which may contribute to its calming effects without acting directly on opioid receptors.
• Cognitive effects: Unlike many sedating anxiolytics, some studies in animal models suggest Selank may actually support memory and learning while producing its calming effect.

How Does It Differ From Benzodiazepines in Research?

Benzodiazepines work by enhancing the effect of GABA at the GABA-A receptor — essentially slowing down the nervous system broadly. Selank appears to work through a fundamentally different set of pathways. Research suggests it does not act on GABA receptors in the same way, which is why the side effect profile in studies looks so different.

For researchers specifically studying anxiety without wanting to introduce the confounding variables that come with GABA-modulating compounds, this makes Selank a uniquely clean research tool.

Why Does the Biohacking Research Community Find It Interesting?

The biohacking and longevity research community tends to be interested in compounds that improve function without significant trade-offs. A peptide that research suggests reduces anxiety without causing sedation, cognitive dulling, or dependence signals checks a lot of boxes. Selank has become one of the more discussed peptides in cognitive enhancement research as a result.

All products sold by PeptiVigor are strictly for laboratory research and analytical purposes only. Not for human or veterinary use.

Explore research-grade Selank at peptivigor.com — check out Selank 30mg. Use code LABVIP1 at checkout to get 15% off your order.